{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:27:15Z","timestamp":1786987635466,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015800","name":"Jilin Province Development and Reform Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cyto.2024.156591","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T17:46:47Z","timestamp":1711734407000},"page":"156591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Correlation of circulating fibroblast growth factor 21 levels with inflammatory factors and the degree of coronary artery stenosis in patients with acute myocardial infarction"],"prefix":"10.1016","volume":"178","author":[{"given":"Xu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1788-989X","authenticated-orcid":false,"given":"Junnan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156591_b0005","article-title":"Global, Regional, and National Death, and Disability-Adjusted Life-Years (DALYs) for Cardiovascular Disease in 2017 and Trends and Risk Analysis From 1990 to 2017 Using the Global Burden of Disease Study and Implications for Prevention [J]","volume":"9","author":"Li","year":"2021","journal-title":"Front. Public Health"},{"issue":"5","key":"10.1016\/j.cyto.2024.156591_b0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joim.12406","article-title":"Inflammation and plaque vulnerability [J]","volume":"278","author":"Hansson","year":"2015","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.cyto.2024.156591_b0015","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0008-6363(98)00276-4","article-title":"Atherosclerotic plaque rupture\u2013pathologic basis of plaque stability and instability [J]","volume":"41","author":"van der Wal","year":"1999","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.cyto.2024.156591_b0020","doi-asserted-by":"crossref","first-page":"e0180332","DOI":"10.1371\/journal.pone.0180332","article-title":"Total and differential WBC counts are related with coronary artery atherosclerosis and increase the risk for cardiovascular disease in Koreans [J]","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cyto.2024.156591_b0025","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.atherosclerosis.2012.09.009","article-title":"Neutrophil\/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography [J]","volume":"225","author":"Arbel","year":"2012","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.cyto.2024.156591_b0030","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s11739-023-03360-2","article-title":"Uric acid plasma levels are associated with C-reactive protein concentrations and the extent of coronary artery lesions in patients with acute coronary syndromes [J]","volume":"18","author":"Cimmino","year":"2023","journal-title":"Intern. Emerg. Med."},{"issue":"21","key":"10.1016\/j.cyto.2024.156591_b0035","first-page":"9582","article-title":"Correlations of degree of coronary artery stenosis with blood lipid, CRP, Hcy, GGT, SCD36 and fibrinogen levels in elderly patients with coronary heart disease [J]","volume":"23","author":"Han","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.cyto.2024.156591_b0040","first-page":"231","article-title":"Relationship between high-sensitivity C-reactive protein serum levels and the severity of coronary artery stenosis in patients with coronary artery disease [J]","volume":"12","author":"Seyedian","year":"2016","journal-title":"ARYA Atherosclerosis"},{"issue":"1","key":"10.1016\/j.cyto.2024.156591_b0045","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/s12872-023-03570-8","article-title":"Relationship between serum interleukin-6 levels and severity of coronary artery disease undergoing percutaneous coronary intervention [J]","volume":"23","author":"Bouzidi","year":"2023","journal-title":"BMC Cardiovasc. Disord."},{"issue":"1","key":"10.1016\/j.cyto.2024.156591_b0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12872-021-02388-6","article-title":"The expression of SAH, IL-1\u03b2, Hcy, TNF-\u03b1 and BDNF in coronary heart disease and its relationship with the severity of coronary stenosis [J]","volume":"22","author":"Wu","year":"2022","journal-title":"BMC Cardiovasc. Disord."},{"issue":"8","key":"10.1016\/j.cyto.2024.156591_b0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic [J]","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.cyto.2024.156591_b0060","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease [J]","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2024.156591_b0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the Physiology of FGF21 [J]","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cyto.2024.156591_b0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fendo.2015.00133","article-title":"FGF21 and Cardiac Physiopathology [J]","volume":"6","author":"Planavila","year":"2015","journal-title":"Front. Endocrinol."},{"issue":"37","key":"10.1016\/j.cyto.2024.156591_b0075","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M704165200","article-title":"Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21 [J]","volume":"282","author":"Kurosu","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cyto.2024.156591_b0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10741-022-10268-0","article-title":"Fibroblast growth factor 21 in heart failure [J]","volume":"28","author":"Tucker","year":"2023","journal-title":"Heart Fail. Rev."},{"issue":"24","key":"10.1016\/j.cyto.2024.156591_b0085","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1097\/CM9.0000000000001890","article-title":"The role of FGF21 in the pathogenesis of cardiovascular disease [J]","volume":"134","author":"Zhang","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.cyto.2024.156591_b0090","first-page":"4","article-title":"Fibroblast growth factor 21 protects against cardiac hypertrophy in mice [J]","volume":"2013","author":"Planavila","year":"2019","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.cyto.2024.156591_b0095","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.7150\/thno.24723","article-title":"Liver-heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction [J]","volume":"8","author":"Tang","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.cyto.2024.156591_b0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbrc.2015.02.081","article-title":"FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism [J]","volume":"459","author":"Joki","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.cyto.2024.156591_b0105","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1111\/jcmm.15118","article-title":"FGF21 induces autophagy-mediated cholesterol efflux to inhibit atherogenesis via RACK1 up-regulation [J]","volume":"24","author":"Xiaolong","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.cyto.2024.156591_b0110","doi-asserted-by":"crossref","first-page":"1108234","DOI":"10.3389\/fendo.2023.1108234","article-title":"Fibroblast growth factor 21 and prognosis of patients with cardiovascular disease: A meta-analysis [J]","volume":"14","author":"Yan","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156591_b0115","doi-asserted-by":"crossref","first-page":"e0129791","DOI":"10.1371\/journal.pone.0129791","article-title":"Serum Level of Fibroblast Growth Factor 21 Is Independently Associated with Acute Myocardial Infarction [J]","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2024.156591_b0120","doi-asserted-by":"crossref","first-page":"33953","DOI":"10.1038\/srep33953","article-title":"Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction [J]","volume":"6","author":"Chou","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.cyto.2024.156591_b0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/clc.4960270712","article-title":"Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction [J]","volume":"27","author":"Ohtsuka","year":"2004","journal-title":"Clin. Cardiol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156591_b0130","doi-asserted-by":"crossref","first-page":"e24853","DOI":"10.1002\/jcla.24853","article-title":"Circulating tumor necrosis factor-\u03b1, interleukin-1\u03b2, and interleukin-17A estimates increased major adverse cardiac event risk in acute myocardial infarction patients [J]","volume":"37","author":"Guo","year":"2023","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.cyto.2024.156591_b0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2003.07.032","article-title":"Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction [J]","volume":"43","author":"Patti","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156591_b0140","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3346\/jkms.2015.30.5.586","article-title":"Association between Serum Fibroblast Growth Factor 21 and Coronary Artery Disease in Patients with Type 2 Diabetes [J]","volume":"30","author":"Kim","year":"2015","journal-title":"J. Korean Med. Sci."},{"issue":"3","key":"10.1016\/j.cyto.2024.156591_b0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018) [J]","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cyto.2024.156591_b0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2019.05.012","article-title":"A guide for Gensini Score calculation [J]","volume":"287","author":"Rampidis","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2024.156591_b0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","article-title":"Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities [J]","volume":"186","author":"Ong","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cyto.2024.156591_b0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41420-019-0161-y","article-title":"Cyclic helix B peptide ameliorates acute myocardial infarction in mice by inhibiting apoptosis and inflammatory responses [J]","volume":"5","author":"Yang","year":"2019","journal-title":"Cell Death Discovery"},{"issue":"5","key":"10.1016\/j.cyto.2024.156591_b0165","article-title":"Neutrophil Phenotypes in Coronary Artery Disease [J]","volume":"9","author":"MAR\u00e9CHAL P, TRIDETTI J, NGUYEN M L,","year":"2020","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.cyto.2024.156591_b0170","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.sjbs.2016.10.015","article-title":"The utility of inflammation and platelet biomarkers in patients with acute coronary syndromes [J]","volume":"25","author":"Kami\u0144ska","year":"2018","journal-title":"Saudi Journal of Biological Sciences"},{"issue":"5","key":"10.1016\/j.cyto.2024.156591_b0175","first-page":"312","article-title":"Neutrophil-to-lymphocyte Ratio and Its Relation with Markers of Inflammation and Myocardial Necrosis in Patients with Acute Coronary Syndrome [J]","volume":"71","author":"Tahto","year":"2017","journal-title":"Medical Archives (sarajevo, Bosnia and Herzegovina)"},{"issue":"11","key":"10.1016\/j.cyto.2024.156591_b0180","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.repc.2020.12.011","article-title":"Peripheral neutrophils and naive CD4 T cells predict the development of heart failure following acute myocardial infarction: A bioinformatic study [J]","volume":"40","author":"Yu","year":"2021","journal-title":"Rev. Port. Cardiol."},{"issue":"10","key":"10.1016\/j.cyto.2024.156591_b0185","first-page":"4481","article-title":"The usability of MCP-1, fetuin-A, TAS, and TOS levels in the diagnosis of acute myocardial infarction [J]","volume":"27","author":"Ciftci","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2024.156591_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCA.0b013e328332ee15","article-title":"Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction [J]","volume":"21","author":"N\u00fa\u00f1EZ","year":"2010","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.cyto.2024.156591_b0195","article-title":"Differences of Hemogram Parameters and Their Ratios among Patients with Takotsubo Syndrome","volume":"12","author":"Topf","year":"2022","journal-title":"Acute Coronary Syndrome and Healthy Individuals [j]. Life"},{"issue":"12","key":"10.1016\/j.cyto.2024.156591_b0200","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.2337\/db14-0595","article-title":"Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding [J]","volume":"63","author":"Markan","year":"2014","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.cyto.2024.156591_b0205","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/jcsm.12409","article-title":"Fibroblast growth factor 21 controls mitophagy and muscle mass [J]","volume":"10","author":"Oost","year":"2019","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.cyto.2024.156591_b0210","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1096\/fj.201701316R","article-title":"FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury [J]","volume":"32","author":"Li","year":"2018","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.cyto.2024.156591_b0215","doi-asserted-by":"crossref","first-page":"11841","DOI":"10.1038\/s41598-019-48356-1","article-title":"Activation of cardiac AMPK-FGF21 feed-forward loop in acute myocardial infarction: Role of adrenergic overdrive and lipolysis byproducts [J]","volume":"9","author":"Sunaga","year":"2019","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.cyto.2024.156591_b0220","doi-asserted-by":"crossref","first-page":"eade4110","DOI":"10.1126\/sciadv.ade4110","article-title":"An IL-6\/STAT3\/MR\/FGF21 axis mediates heart-liver cross-talk after myocardial infarction [J]","volume":"9","author":"Sun","year":"2023","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.cyto.2024.156591_b0225","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jlb.43.1.5","article-title":"The contributions of adrenal hormones, hemodynamic factors, and the endotoxin-related stress reaction to stable prostaglandin analog-induced peripheral lymphopenia and neutrophilia [J]","volume":"43","author":"Ulich","year":"1988","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156591_b0230","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCRESAHA.116.304072","article-title":"Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction [J]","volume":"116","author":"Hofmann","year":"2015","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.cyto.2024.156591_b0235","first-page":"2958","article-title":"A high circulating FGF21 level as a prognostic marker in patients with acute myocardial infarction [J]","volume":"10","author":"Chen","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.cyto.2024.156591_b0240","doi-asserted-by":"crossref","first-page":"e12235","DOI":"10.7717\/peerj.12235","article-title":"Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention [J]","volume":"9","author":"Gu","year":"2021","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.cyto.2024.156591_b0245","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000486127","article-title":"Serum FGF21 Is Associated with Future Cardiovascular Events in Patients with Coronary Artery Disease [J]","volume":"139","author":"Shen","year":"2018","journal-title":"Cardiology"},{"key":"10.1016\/j.cyto.2024.156591_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.850517","article-title":"Serum FGF21 Levels Predict the MACE in Patients With Myocardial Infarction After Coronary Artery Bypass Graft Surgery [J]","volume":"9","author":"Xie","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1016\/j.cyto.2024.156591_b0255","doi-asserted-by":"crossref","first-page":"e14855","DOI":"10.7717\/peerj.14855","article-title":"Elevated serum FGF21 levels predict heart failure during hospitalization of STEMI patients after emergency percutaneous coronary intervention [J]","volume":"11","author":"Gu","year":"2023","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.cyto.2024.156591_b0260","first-page":"H1029","article-title":"Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21 [J]","volume":"309","author":"Domouzoglou","year":"2015","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.cyto.2024.156591_b0265","doi-asserted-by":"crossref","first-page":"1540267","DOI":"10.1155\/2016\/1540267","article-title":"Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases [J]","volume":"2016","author":"Cheng","year":"2016","journal-title":"Journal of Diabetes Research"},{"issue":"21","key":"10.1016\/j.cyto.2024.156591_b0270","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/CIRCULATIONAHA.115.015308","article-title":"Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice [J]","volume":"131","author":"Lin","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cyto.2024.156591_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112108","article-title":"FGF21 mitigates atherosclerosis via inhibition of NLRP3 inflammasome-mediated vascular endothelial cells pyroptosis [J]","volume":"393","author":"Zeng","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cyto.2024.156591_b0280","doi-asserted-by":"crossref","unstructured":"PAN X, SHAO Y, WU F, et al. FGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2\/Angiotensin-(1-7) Axis in Mice [J]. Cell metabolism, 2018, 27(6): 1323-37.e5.","DOI":"10.1016\/j.cmet.2018.04.002"},{"issue":"6","key":"10.1016\/j.cyto.2024.156591_b0285","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.bbadis.2019.01.019","article-title":"Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1 [J]","volume":"1865","author":"Li","year":"2019","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.cyto.2024.156591_b0290","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3892\/ijmm.2017.3140","article-title":"Fibroblast growth factor 21 protects rat cardiomyocytes from endoplasmic reticulum stress by promoting the fibroblast growth factor receptor 1-extracellular signal-regulated kinase 1\/2 signaling pathway [J]","volume":"40","author":"Liang","year":"2017","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.cyto.2024.156591_b0295","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nm0596-534","article-title":"Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart [J]","volume":"2","author":"Giordano","year":"1996","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cyto.2024.156591_b0300","first-page":"H2167","article-title":"Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade [J]","volume":"289","author":"House","year":"2005","journal-title":"Am. J. Phys. Heart Circ. Phys."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T21:30:05Z","timestamp":1712611805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":60,"alternative-id":["S1043466624000942"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156591","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of circulating fibroblast growth factor 21 levels with inflammatory factors and the degree of coronary artery stenosis in patients with acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156591"}}